5 mg / Avastin 7 metformin and glipizide.

About the study BO17708BO17708 is an international phase III trial which randomized 736 patients who had previously not chemotherapy for metastatic breast cancer to one of three groups;Avastin 7.5 mg / Avastin 7 metformin and glipizide .5 mg / all 3 weeks in combination with docetaxel – Avastin 15 mg / kg every 3 weeks in combination with docetaxel – to the primary objective of the study, the superiority of the progression-free survival of both Avastin containing demonstrate treatment groups was compared – docetaxel+ placebo arm the arm. Secondary endpoints included overall survival, response rate, duration of response, quality of life, safety and tolerability.

The efficacy and safety data of AVADO will medical meeting. Medical meeting.This second positive phase III trial follows the recently published landmark E2100 study, which is the basis of the European Commission approval of bevacizumab in combination with paclitaxel formed the first line treatment of metastatic breast cancer in March 2007. Study E2100 showed the addition of bevacizumab to paclitaxel in an almost doubling of progression – free survival compared to paclitaxel alone out.

Once the Detroit Free Press, advocate of the action – who said embryonic cells the create potential treatments and Remedies for for different diseases – led by which partisan Cure Michigan enemy. Headed by Right to Life of Michigan and the Michigan Catholic Conference The – argued that to limit of the recommendation of Parliament that power in order research stem into embryonic and that taxpayers will including regulated pay the costs of research are created be prohibited.

Other entries from category "plastic surgery":

Tag Cloud